<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="methods-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2022.1068990</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Neuroscience</subject>
<subj-group>
<subject>Methods</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>Ex vivo</italic> analysis platforms for monitoring amyloid precursor protein cleavage</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Kamikubo</surname><given-names>Yuji</given-names></name>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1192246/overview"/>
</contrib>
<contrib contrib-type="author"><name><surname>Jin</surname><given-names>Hao</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Yiyao</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Niisato</surname><given-names>Kazue</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Hashimoto</surname><given-names>Yoshie</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Takasugi</surname><given-names>Nobumasa</given-names></name>
<uri xlink:href="https://loop.frontiersin.org/people/837887/overview"/>
</contrib>
<contrib contrib-type="author"><name><surname>Sakurai</surname><given-names>Takashi</given-names></name>
</contrib>
</contrib-group>
<aff><institution>Department of Pharmacology, Juntendo University School of Medicine</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by">
<p>Edited by: Rosa Chiara Paolicelli, Universit&#x00E9; de Lausanne, Switzerland</p>
</fn>
<fn id="fn0002" fn-type="edited-by">
<p>Reviewed by: Giuseppe Caruso, University of Catania, Italy; Yo Shinoda, Tokyo University of Pharmacy and Life Sciences, Japan; Sasanka Chakrabarti, Maharishi Markandeshwar University, Mullana, India</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Yuji Kamikubo, <email>ykamiku@juntendo.ac.jp</email></corresp>
<fn id="fn0003" fn-type="other">
<p>This article was submitted to Methods and Model Organisms, a section of the journal Frontiers in Molecular Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>15</volume>
<elocation-id>1068990</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Kamikubo, Jin, Zhou, Niisato, Hashimoto, Takasugi and Sakurai.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Kamikubo, Jin, Zhou, Niisato, Hashimoto, Takasugi and Sakurai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Alzheimer&#x2019;s disease (AD) is a progressive neurodegenerative brain disorder and the most common cause of dementia in the elderly. The presence of large numbers of senile plaques, neurofibrillary tangles, and cerebral atrophy is the characteristic feature of AD. Amyloid &#x03B2; peptide (A&#x03B2;), derived from the amyloid precursor protein (APP), is the main component of senile plaques. AD has been extensively studied using methods involving cell lines, primary cultures of neural cells, and animal models; however, discrepancies have been observed between these methods. Dissociated cultures lose the brain&#x2019;s tissue architecture, including neural circuits, glial cells, and extracellular matrix. Experiments with animal models are lengthy and require laborious monitoring of multiple parameters. Therefore, it is necessary to combine these experimental models to understand the pathology of AD. An experimental platform amenable to continuous observation and experimental manipulation is required to analyze long-term neuronal development, plasticity, and progressive neurodegenerative diseases. In the current study, we provide a practical method to slice and cultivate rodent hippocampus to investigate the cleavage of APP and secretion of A&#x03B2; in an <italic>ex vivo</italic> model. Furthermore, we provide basic information on A&#x03B2; secretion using slice cultures. Using our optimized method, dozens to hundreds of long-term stable slice cultures can be coordinated simultaneously. Our findings are valuable for analyses of AD mouse models and senile plaque formation culture models.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer&#x2019;s disease</kwd>
<kwd>amyloid &#x03B2;</kwd>
<kwd>neurodegenerative disease</kwd>
<kwd>organotypic brain culture</kwd>
<kwd>hippocampus</kwd>
<kwd>secretase</kwd>
</kwd-group>
<contract-num rid="cn1">JP20K07765 and JP17K09040</contract-num>
<contract-sponsor id="cn1">JSPS KAKENHI</contract-sponsor>
<contract-sponsor id="cn2">TERUMO LIFE SCIENCE FOUNDATION</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="57"/>
<page-count count="14"/>
<word-count count="9227"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>Organotypic brain cultures, including slice cultures, are used to study the central nervous system owing to their advantages over both <italic>in vivo</italic> and <italic>in vitro</italic> research platforms (<xref ref-type="bibr" rid="ref9">Cho et al., 2007</xref>; <xref ref-type="bibr" rid="ref52">Uesaka et al., 2018</xref>). Sophisticated cultured brain slices retain tissue structure, neural circuit, and extracellular environment and replicate the native status of the <italic>in vivo</italic> context. Hippocampal slice cultures are widely used to investigate the effects of pharmacological, biochemical, physiological, and genetic manipulation on neuronal and glial cells (<xref ref-type="bibr" rid="ref2">Bergold et al., 1993</xref>; <xref ref-type="bibr" rid="ref21">Ikegaya, 1999</xref>). Three typical methods are used to maintain neural tissue <italic>in vitro</italic>: roller-tube cultures, matrix-embedded cultures, and membrane interfaces (<xref ref-type="bibr" rid="ref13">G&#x00E4;hwiler et al., 1997</xref>). The membrane interface brain slice culture was improved for practical use by <xref ref-type="bibr" rid="ref49">Stoppini et al. (1991)</xref>. Since a sterilized filter membrane cup is designed to easily change the medium, this apparatus as an interface is helpful for the long-term maintenance of the explant tissue. Cultured hippocampal slices on the filter membrane cup were amenable to complete replacements of the culture medium. These advantages allowed us to keep the brain slices in culture for several months. Previously, we reported on neural circuits, synaptic plasticity, neurodevelopment, and neurodegenerative diseases using cultured hippocampal slices (<xref ref-type="bibr" rid="ref50">Tominaga-Yoshino et al., 2002</xref>; <xref ref-type="bibr" rid="ref47">Shinoda et al., 2005</xref>; <xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>).</p>
<p>Alzheimer&#x2019;s disease (AD) is a chronic neurodegenerative brain disorder that usually starts slowly and worsens over a long period and is the most common cause of dementia in the elderly. Numerous genetic and biochemical studies have supported the hypothesis that excessive accumulation of amyloid &#x03B2; peptide (A&#x03B2;) results in aggregation and amyloid deposition in the brains of patients with AD (amyloid hypothesis) (<xref ref-type="bibr" rid="ref14">Hardy and Selkoe, 2002</xref>). A&#x03B2; is derived from the amyloid precursor protein (APP), an integral type I membrane protein expressed in many tissues and concentrated in synapses. APP is commonly cleaved by membrane proteases in the secretase family: &#x03B1;-, &#x03B2;-, and &#x03B3;-secretase. A&#x03B2; is generated by sequential cleavage by &#x03B2;-secretase (BACE1) (<xref ref-type="bibr" rid="ref54">Vassar et al., 1999</xref>) and &#x03B3;-secretase, whereas alternative cleavage by &#x03B1;-secretase prevents A&#x03B2; production (<xref ref-type="bibr" rid="ref12">De Strooper and Annaert, 2000</xref>). Since neuronal activity is known to be an important regulator of APP &#x03B2; cleavage (<xref ref-type="bibr" rid="ref25">Kamenetz et al., 2003</xref>; <xref ref-type="bibr" rid="ref43">Sakurai et al., 2008</xref>), the regulation of cleavage, accumulation, and elimination of A&#x03B2; have been explored as a target for the therapy and prevention of AD.</p>
<p>A&#x03B2; is the main component of highly insoluble senile plaques in AD brain, but it is also known to form soluble and highly toxic aggregate, oligomers. Although amyloid plaques have been the first focus of study in the amyloid hypothesis, it has recently become clear that many toxic factors, including A&#x03B2; oligomers (<xref ref-type="bibr" rid="ref11">Cline et al., 2018</xref>), are present. A&#x03B2; and other peptide oligomers have been reported to cause cytotoxicity and neurodegeneration (<xref ref-type="bibr" rid="ref7">Caruso et al., 2019</xref>). On the other hand, APP cleavage products other than A&#x03B2; have been reported to be neurotoxic or neuroprotective (<xref ref-type="bibr" rid="ref8">Chasseigneaux and Allinquant, 2012</xref>; <xref ref-type="bibr" rid="ref56">Willem et al., 2015</xref>; <xref ref-type="bibr" rid="ref30">Kaneshiro et al., 2022</xref>). Furthermore, previous studies showed that A&#x03B2; itself induces the secretion of neuroprotective factors (<xref ref-type="bibr" rid="ref59">Zimbone et al., 2018</xref>). To elucidate the early pathogenesis of AD, it is necessary to clarify the function and behavior of A&#x03B2; monomers, oligomers, and other APP cleavage products.</p>
<p>A large amount of data from cell line model-based assays has revealed the molecular mechanism of A&#x03B2; secretion to understand AD (<xref ref-type="bibr" rid="ref14">Hardy and Selkoe, 2002</xref>). Although cell line models are powerful tools for molecular biological studies, discordance has been observed between cell lines and animal models. Since neuronal and glial cells are morphologically and functionally specialized, dissociated primary cultures of neuronal tissues have the advantage of revealing the pathological processes and molecular mechanisms of neuropsychiatric disorders. Although experiments using cultured neurons provide important information, they exhibit loss of the tissue architecture of the brain. Since neural circuits, glial networks, and extracellular environments are essential in neurodevelopment, and neurodegenerative diseases, including AD, analysis using cultured neurons alone is insufficient (<xref ref-type="bibr" rid="ref54">Vassar et al., 1999</xref>; <xref ref-type="bibr" rid="ref20">Ichikawa-Tomikawa et al., 2012</xref>; <xref ref-type="bibr" rid="ref23">Irie et al., 2012</xref>; <xref ref-type="bibr" rid="ref46">Sethi and Zaia, 2017</xref>). However, several disadvantages are associated with animal model experiments, including the requirement of a long duration, substantial cost, and laborious monitoring of multiple parameters following manipulations. Furthermore, genetically engineered animals may be affected by compensatory and developmental changes (<xref ref-type="bibr" rid="ref32">Kreiner, 2015</xref>). For this reason, hippocampal slice culture may be a potential technique for linking animal models and neural cells.</p>
<p>In the current study, we describe the methods of organotypic hippocampal slice culture and consecutive analysis of A&#x03B2; and related products, which play a central role in the pathogenesis of AD. The hippocampus is thought to be one of the first brain regions to suffer damage in AD (<xref ref-type="bibr" rid="ref19">Hyman et al., 1984</xref>). With the method reported here, we could produce nearly 100 slices in a single cultivation and maintain hippocampal slices for more than 1 month resulting in an increased analysis efficiency. Continuous collection and analysis of A&#x03B2; is a powerful approach for elucidating the cellular and molecular mechanisms underlying AD. Long-term and consecutive analyses are also required to develop and evaluate therapeutic agents and treatment approaches for AD.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec3">
<title>Reagents for slice culture</title>
<p>Slice culture medium (SCM) contained 50% minimal essential medium based on Earle&#x2019;s salts (Nacalai Tesque, Kyoto, Japan, 21,442&#x2013;25) with 72&#x2009;mM glucose and 2&#x2009;mM HEPES added, 25% Hank&#x2019;s Balanced Salt Solution (Thermo Fisher Scientific, 24,020&#x2013;117, MA, United States), and 25% horse serum that was heat-inactivated at 56&#x00B0;C for 30&#x2009;min (Thermo Fisher Scientific, 16,050&#x2013;122). Dissection solution was ice-cold Gey&#x2019;s BSS (GBSS) (137&#x2009;mM NaCl, 5&#x2009;mM KCl, 0.18&#x2009;mM KH<sub>2</sub>PO<sub>4</sub>, 0.84&#x2009;mM Na<sub>2</sub>HPO<sub>4</sub> 12H<sub>2</sub>O, 36&#x2009;mM glucose, 1.5&#x2009;mM CaCl<sub>2</sub>, 1&#x2009;mM MgCl<sub>2</sub>, and 0.32&#x2009;mM MgSO<sub>4</sub>) saturated with O<sub>2</sub>. Phosphate-buffered saline (PBS). 4% paraformaldehyde in Phosphate Buffer Solution (Nacalai Tesque, 09154&#x2013;85). &#x03B1;-secretase inhibitor: GI 254023X (Tocris Bioscience, Bristol, United Kingdom, 3995), &#x03B2;-secretase inhibitor: BACE inhibitor IV (Calbiochem, CA, United States, 565788), &#x03B3;-secretase inhibitors: N-(N-(3,5-difluorophenacetyl)-L-alanyl)-S-phenylglycine t-butyl ester (DAPT, Tokyo Chemical Industry, Tokyo, Japan, D4257). Primary antibodies used were anti-NeuN (a marker protein for neuronal nuclei) (mouse monoclonal, A60, Chemicon, CA, United States); anti-glial fibrillary acidic protein (GFAP) (a marker protein for astrocytes) (mouse monoclonal, SMI22, BioLegend, CA, USA); anti-ionized calcium-binding adapter molecule 1 (Iba1) (a marker protein for microglia) (rabbit, 019&#x2013;19,741; Wako Pure Chemical Industries, Osaka, Japan); anti-BACE1 (rabbit monoclonal) (D10E5, Cell signaling Technology, MA, USA), and anti-APP (mouse monoclonal, 22C11, Millipore, Carrigtwohill, Ireland), anti-nicastrin (a membrane of &#x03B3;-secretase complex) (mouse, 9C3, Biolegend) antibodies. The secondary antibodies used were goat anti-mouse IgG (Alexa Fluor 488, A-11001), goat anti-mouse IgG (Alexa Fluor 594, A-11032), goat anti-rabbit IgG (Alexa Fluor 488, A-11034), and goat anti-rabbit IgG (Alexa Fluor 594, A-11037) (Thermo Fisher Scientific, MA, USA). RIPA buffer consisted of 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 25&#x2009;mM Tris&#x2013;HCl, pH 7.5, 137&#x2009;mM NaCl, and 3&#x2009;mM KCl with a protease inhibitor cocktail (Complete, Roche Diagnostics, Mannheim, Germany). Furthermore, 1&#x00D7; Tris-buffered saline (TBS) consisted of 50&#x2009;mM Tris, 138&#x2009;mM NaCl, and 2.7&#x2009;mM KCl. TBST consisted of 1&#x00D7; TBS with 0.1% Tween 20 added. The mouse/rat amyloid &#x03B2;(1&#x2013;40) assay kit (27720), mouse/rat amyloid &#x03B2;(1&#x2013;42) assay kit (27721), mouse/rat sAPP&#x03B1; (highly sensitive) assay kit (27419), and mouse sAPP&#x03B2;-w Assay Kit (27416) were purchased from IBL, Gunma, Japan.</p>
</sec>
<sec id="sec4">
<title>Apparatus for slice culture</title>
<p>Tissue chopper (McIlwain), double-edge stainless steel cutting blades (FEATHER, FA-10), disposable scalpel (FEATHER, No.11, No. 22), filter membrane cup (Millicell-CM, Millipore, PICM03050 or PICM0RG50), stereomicroscope (Olympus, Tokyo, Japan, SZX7), and overhead projector (OHP) sheet cut into 5-cm squares were used for slice culture.</p>
</sec>
<sec id="sec5">
<title>Hippocampal slice culture method</title>
<p>All animal experiments were conducted in strict accordance with the institutional guidelines of Juntendo University for animal experiments. The protocol was approved by the Animal Experimentation Committee of Juntendo University (no. 845, 1,187). All animals were kept in an environment at 24&#x00B0;C with a 12-h light/dark cycle, with water and food freely available. At the end of the experiment, the animals were euthanized by exposure to carbon dioxide (CO<sub>2</sub>) or decapitation. Death was verified by respiratory arrest and dilated pupils. All surgical procedures were performed under carbon dioxide (CO<sub>2</sub>) anesthesia, and every effort was made to minimize animal suffering.</p>
<p>The hippocampal slice culture procedure in this study was an improvement of the method used in previous studies (<xref ref-type="bibr" rid="ref50">Tominaga-Yoshino et al., 2002</xref>; <xref ref-type="bibr" rid="ref26">Kamikubo et al., 2006</xref>, <xref ref-type="bibr" rid="ref27">2017</xref>). In this experiment, the Sprague&#x2013;Dawley rat (postnatal days (P) 6&#x2013;8, <italic>n</italic>&#x2009;=&#x2009;80 in total) and Institute of Cancer Research (ICR) mice (P 7&#x2013;8, <italic>n</italic>&#x2009;=&#x2009;12 in total) purchased from Nihon SLC (Hamamatsu, Japan). For slice culture, adult rats or mice were euthanized by CO<sub>2</sub>, pups were euthanized by decapitation after CO<sub>2</sub>-anesthesia (<xref ref-type="bibr" rid="ref51">Turner et al., 2020</xref>). The hippocampi were isolated after euthanasia.</p>
<p>The 400&#x2009;&#x03BC;m thick hippocampal slices were obtained from the central region of the hippocampus using a tissue chopper with a cutting blade (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). The slices were placed in the center of the filter membrane cups, and SCM was added to the bottom surface of the filter (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). The prepared cultures were maintained at 37&#x00B0;C and 5% CO<sub>2</sub>. The culture medium was replaced twice per week with fresh medium throughout the culture period.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Schematic diagrams and photographs of procedure for hippocampal slice culture. <bold>(A)</bold> Schema of hippocampal slice culture method. <bold>(B)</bold> Schema representing disposition of slice on membrane culture insert and within the culture dish. SCM: slice culture medium. <bold>(C)</bold> Image of isolated hippocampi (H) with cerebral cortex (c). <bold>(D)</bold> Image of tissue chopper and isolated hippocampi with the cerebral cortex. Six hippocampi were placed on an OHP sheet in the cutting chamber. <bold>(E)</bold> Sliced hippocampus (h) with the cortex (c) and isolated hippocampus. <bold>(F)</bold> Five slices were placed onto the filter membrane cup in the six-well plate with SCM. Hippocampal slices are not located close to the cup walls of the inserts or close to each other.</p>
</caption>
<graphic xlink:href="fnmol-15-1068990-g001.tif"/>
</fig>
</sec>
<sec id="sec6">
<title>Protocol</title>
<p>The optimized protocol developed based on previous studies on long-term culture of multiple hippocampal slices is as follows (<xref ref-type="bibr" rid="ref49">Stoppini et al., 1991</xref>; <xref ref-type="bibr" rid="ref28">Kamikubo et al., 2021</xref>). Since sterile slicing is critical for long-term culture, we modified previous slicing method to use sterile OHP sheets (Step 7&#x2013;9). To avoid damaging the hippocampus, we modified previous method of dividing the hippocampal slices one by one (Step 10).</p>
<list list-type="order">
<list-item>
<p>Wipe the stereomicroscope, tissue chopper, and micropipette with 70% ethanol solution. Sterilize the dissecting instruments and a cutting blade by immersing them in a 70% ethanol solution for 30&#x2009;min. In addition, sterilize them for 30&#x2009;min with UV light on a clean bench.</p>
</list-item>
<list-item>
<p>Dispense GBSS into a sterilized 100&#x2009;ml bottle and place it on an ice box. Bubble the GBSS with 100% O<sub>2</sub> for 20&#x2013;30&#x2009;min (40&#x2013;50&#x2009;ml GBSS is required per culture session [2&#x2013;4 pups]). Owing to the high oxygen demand of the central nervous system, the working solution needs to be sufficiently oxygenated and cooled. Oxygen is blown through a long needle with a syringe filter to aseptically oxygenate the working solution.</p>
</list-item>
<list-item>
<p>Place the tissue chopper on a clean bench, attach a sterilized blade, and place the autoclaved OHP sheet on the cutting chamber.</p>
</list-item>
<list-item>
<p>Prepare a 6-well plate or 35-mm dishes, add 1&#x2009;ml of SCM per well, and place a culture insert in each well. Carefully check that the filter membrane of the insert is completely wet and free of air bubbles underneath. Place the plates or dishes with culture inserts maintained at 37&#x00B0;C, 5% CO<sub>2</sub>, until needed.</p>
</list-item>
<list-item>
<p>The rodent pups were euthanized by decapitation after CO<sub>2</sub>-anesthesia. Cut the scalp along the midline to expose the skull. Cut along the sagittal suture and remove the skull from the rostral to the caudal. Quickly scoop out the brain with a micro medicine spoon and place it in oxygenated GBSS on ice.</p>
</list-item>
<list-item>
<p>Place the brain on an autoclave filter paper soaked in ice-cold oxygenated GBSS in a 100-mm dish. Using a scalpel, remove the midbrain and cerebellum, and then separate the hemisphere.</p>
</list-item>
<list-item>
<p>Under the stereomicroscope, gently remove the thalamus. The hippocampi are then exposed on each hemisphere in ice-cold oxygenated GBSS. Then, gently scoop the hippocampus out with the cortex using a micro spoon (<xref rid="fig1" ref-type="fig">Figure 1C</xref>).</p>
</list-item>
<list-item>
<p>Transfer the hippocampus to the OHP sheet on the tissue chopper chamber. Align the hippocampi perpendicular to the blade, drain excess GBSS, and obtain the coronal sections (<xref rid="fig1" ref-type="fig">Figure 1D</xref>).</p>
</list-item>
<list-item>
<p>Slice the hippocampi every 400&#x2009;&#x03BC;m using a tissue chopper. Since tissue chopper and OHP sheet are placed at room temperature, quick operation is required in slicing the brain.</p>
</list-item>
<list-item>
<p>Transfer sliced hippocampi from the OHP sheet to a 60-mm dish filled with ice-cold oxygenated GBSS. Slicing with an OHP sheet underneath allows the slices to be easily separated in a sterile environment.</p>
</list-item>
<list-item>
<p>Under a stereomicroscope (Olympus, SZX7), pinch the cortex with precision tweezers, and divide the undamaged hippocampal slices one by one. Next, split it into the cerebral cortex and hippocampus with a scalpel (<xref rid="fig1" ref-type="fig">Figure 1E</xref>). It is essential to complete steps 5 to 10 within 45&#x2009;min.</p>
</list-item>
<list-item>
<p>Incubate separated hippocampi in fresh oxygenated GBSS on ice for 30&#x2013;60&#x2009;min.</p>
</list-item>
<list-item>
<p>Transfer individual slices onto the culture inserts in the 6-well plate or 35-mm dish with pre-warmed SCM. Place 1&#x2013;6 slices on one culture insert without placing slices near the walls of the inserts or close to each other (<xref rid="fig1" ref-type="fig">Figure 1F</xref>).</p>
</list-item>
<list-item>
<p>Return the plate or dish to the incubator, and maintain the slices at 37&#x00B0;C with a 5% CO<sub>2</sub>-enriched humidified atmosphere.</p>
</list-item>
<list-item>
<p>Replace with fresh SCM once every 3&#x2013;4&#x2009;days during the culture period. Aspirate the medium in a dish, and add 750&#x2013;800&#x2009;&#x03BC;l of pre-warmed fresh SCM per well. Approximately 200&#x2013;250&#x2009;&#x03BC;l of medium remains in the culture dish and filter membrane. When the sliced brain is immersed in liquid, oxygen deprivation damages nerve cells. To avoid neural cell death, the brain slice is exposed to air and medium that exudes from the filter membrane.</p>
</list-item>
</list>
</sec>
<sec id="sec7">
<title>Immunohistochemical staining</title>
<p>For the immunohistochemical staining, the cultured slices were fixed with 4% paraformaldehyde in PBS for 1&#x2009;h at 4&#x00B0;C. The fixed preparations were rinsed four times with PBS and then treated with PBS containing 0.5% Triton X-100 and 5% fetal bovine or horse serum at 24&#x00B0;C for 30&#x2009;min. The treated slices were incubated with a primary antibody against NeuN (1:200 dilution), GFAP (1:200), and Iba1 (1:100) at 4&#x00B0;C for 24&#x2009;h. Slices treated with primary antibody and washed five times with PBS were incubated with a secondary antibody conjugated with Alexa Fluor 488 or 594 (1:400 dilution) at 24&#x00B0;C for 2&#x2013;2.5&#x2009;h (<xref ref-type="bibr" rid="ref26">Kamikubo et al., 2006</xref>). Cultured slices were examined using an inverted microscope (Olympus, IX71) with an Orca-ER cooled CCD camera (Hamamatsu Photonics, Hamamatsu, Japan) or a Leica SP5/TCS confocal laser scanning microscope (Leica Microsystems, Wetzlar, Germany) (<xref ref-type="bibr" rid="ref42">Sakairi et al., 2020</xref>).</p>
</sec>
<sec id="sec8">
<title>Propidium iodide staining</title>
<p>Propidium iodide (PI; Nacalai) is a red-fluorescent nuclear and chromosome counterstain. Since live cells are not permeable to PI, it is commonly used to detect dead cells in a population. We used PI fluorescence intensity as an index of total neuronal degeneration. Cultured slices were exposed to SCM containing 10&#x2009;&#x03BC;g/ml PI for 5 h. Subsequently, slices were treated with 100&#x2009;&#x03BC;M kainic acid (KA) for 3d to induce neuronal cell death. The whole slice was photographed with identical incident light intensity and exposure time on the fluorescence microscope (IX70 with a 4x objective lens, Olympus). PI fluorescence intensity was measured on all micrographs using MetaMorph software (Molecular Devices, CA, USA).</p>
</sec>
<sec id="sec9">
<title>Electrophoresis and immunoblotting</title>
<p>Acute or cultured hippocampal slices were solubilized in ice-cold RIPA buffer containing a protease inhibitor cocktail (Complete, Roche Diagnostics, Mannheim, Germany). The samples were resolved by SDS-PAGE and transferred onto polyvinylidene fluoride membranes (Immobilon-P, Millipore) (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). Membranes were incubated in 5% skim milk in TBST at 25&#x00B0;C for 30&#x2013;60&#x2009;min to block nonspecific binding. Membranes were incubated overnight at 4&#x00B0;C or at 25&#x00B0;C for 2&#x2009;h with primary antibodies against GFAP (BioLegend), Iba1 (Wako Pure Chemical Industries), anti-galectin-3 (mouse monoclonal, A3A12; Santa Cruz, CA, USA), or anti-&#x03B2;-actin (a loading control; mouse monoclonal; Wako Pure Chemical Industries). After four changes of 1&#x00D7; TBST and three 5-min washes at 25&#x00B0;C, the membranes were incubated in horseradish peroxidase-conjugated secondary antibodies. After four washes at 25&#x00B0;C, the membranes were incubated with an enhanced chemiluminescence solution (ECL western blotting substrate, Thermo Fisher Scientific, MA, USA). For quantification, chemiluminescence light signals in the Super Signal Dura substrate (Thermo Fisher Scientific) were captured using a cooled charge-coupled device camera system (LAS-3000plus; Fuji Photo Film Company, Kanagawa, Japan) that ensured a wide range of linearity. The densitometric quantification of protein expression was normalized to that of GAPDH or &#x03B2;-actin. Protein content was estimated using bicinchoninic acid (BCA, Thermo Fisher Scientific) (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>).</p>
</sec>
<sec id="sec10">
<title>Enzyme immunoassay for amyloid &#x03B2; and soluble APP</title>
<p>A&#x03B2; and soluble APP (sAPP) concentrations in the SCM were measured using an ELISA kit, as previously described (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). The levels of A&#x03B2;<sub>40</sub>, A&#x03B2;<sub>42</sub>, sAPP&#x03B1;, and sAPP&#x03B2; were measured using a solid-phase sandwich ELISA kit according to the supplier&#x2019;s information (IBL, Gunma, Japan). To quantify A&#x03B2; production sequentially, we collected all the culture medium incubated with cultured slices and added 750&#x2009;&#x03BC;l of the new culture medium. A&#x03B2;<sub>40</sub> was quantified by diluting the medium by 10-to 25-fold, and A&#x03B2;<sub>42</sub> was quantified by diluting the culture medium by 2-to 8-fold. Since A&#x03B2; quantification was performed in duplicate, we collected approximately 200&#x2009;&#x03BC;l of the culture medium.</p>
</sec>
<sec id="sec11">
<title>Drug application</title>
<p>We assessed secretase dependency on APP processing in the culture system using &#x03B1;-, &#x03B2;-, and &#x03B3;-secretase inhibitors (GI254023X, BACE inhibitor IV, and DAPT). Briefly, we incubated cultured hippocampal slices (14 DIV) or dissociated hippocampal cells (14 DIV) with 10&#x2009;&#x03BC;M DAPT, secretase inhibitor mix (10&#x2009;&#x03BC;M DAPT, 50&#x2009;&#x03BC;M GI254023X, and 2&#x2009;&#x03BC;M BACE inhibitor IV), or vehicle (DMSO) for 24&#x2009;h. The GI254023X, BACE inhibitor IV, and DAPT were dissolved in DMSO (Sigma-Aldrich, MI, United States) to concentrations 500 and 1,000 times higher than the final levels, respectively, and kept at &#x2212;20&#x00B0;C until use. GI 254023X and BACE inhibitor IV were added to fresh SCM before the analysis (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). Other test drugs were dissolved in water to concentrations 1,000 times higher than the final levels, kept at 4 or&#x2009;&#x2212;&#x2009;20&#x00B0;C until use, and diluted into medium unless otherwise stated.</p>
</sec>
<sec id="sec12">
<title>Statistical analysis</title>
<p>All quantitative data are presented as mean&#x2009;&#x00B1;&#x2009;standard deviation (SD). Statistical analysis was performed using either Student&#x2019;s <italic>t</italic>-test (two-group comparison) or ANOVA (more than two groups), followed by a <italic>post hoc</italic> comparison. Multiple comparisons between groups were made by Tukey&#x2013;Kramer test. The level of significance is indicated by asterisks: &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001.</p>
</sec>
</sec>
<sec id="sec13" sec-type="results">
<title>Results</title>
<sec id="sec14">
<title>Chronological analysis of cultured hippocampal slices</title>
<p>Previously, we reported that cultured rat hippocampal slices retained their neuronal activity for several weeks (<xref ref-type="bibr" rid="ref47">Shinoda et al., 2005</xref>; <xref ref-type="bibr" rid="ref26">Kamikubo et al., 2006</xref>). We recently showed that the reorganization and maturation of synapses occur in cultured hippocampal slices (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). In the current study, we investigated the morphological features of neuronal and glial cells in hippocampal slice cultures after 3&#x2013;62&#x2009;days <italic>in vitro</italic> (DIV) (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>). We showed immunohistochemical staining images of 29 DIV in the middle of the culture period (<xref rid="fig2" ref-type="fig">Figures 2A</xref>&#x2013;<xref rid="fig2" ref-type="fig">C</xref>). To observe glial cells, we performed immunostaining for GFAP and Iba1. GFAP is a hallmark intermediate filament protein in astrocytes (<xref ref-type="bibr" rid="ref17">Hol and Pekny, 2015</xref>). Iba1 is a microglial macrophage-specific protein (<xref ref-type="bibr" rid="ref22">Imai et al., 1996</xref>). In the slice culture, astroglia and microglia were distributed throughout the slice, and the arrangement of neurons was maintained. Hippocampal subregions, such as the dentate gyrus (DG), CA1, and CA3, could be clearly discerned (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). APP and BACE1 expression in cultured hippocampal slices accumulated in the stratum radiatum, similar to the <italic>in vivo</italic> distribution (<xref ref-type="bibr" rid="ref29">Kandalepas et al., 2013</xref>) (<xref ref-type="supplementary-material" rid="SM2">Supplementary Figure S2</xref>). Total protein levels in hippocampal slices did not change dramatically after 7 DIV (<xref rid="fig2" ref-type="fig">Figure 2D</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Chronological analysis of neuronal cells in cultured hippocampal slices. <bold>(A&#x2013;C)</bold> Immunofluorescence staining of cultured hippocampal slices antibodies against NeuN <bold>(A)</bold>, GFAP <bold>(B)</bold>, and Iba1 <bold>(C)</bold>. CA1, Cornu Ammonis 1; CA3, Cornu Ammonis 3; DG, dentate gyrus. The scale indicates 500&#x2009;&#x03BC;m. <bold>(D)</bold> Quantitative analysis of total protein in the lysate from four acute slices (0&#x2009;days <italic>in vitro</italic>; DIV) or cultured slices (1&#x2013;56 DIV). <bold>(E&#x2013;I)</bold> Immunoblotting analysis of hippocampal slices with antibodies against &#x03B2;III tubulin <bold>(F)</bold>, GFAP <bold>(G)</bold>, Iba1 <bold>(H)</bold>, and galectin-3 <bold>(I)</bold>. Each point (filled circle) denotes relative protein expression which was normalized to &#x03B2;-actin and relative to a 0 DIV (acute slice) sample. Full-length blots: <xref ref-type="supplementary-material" rid="SM4">Supplementary Figures S4, S5</xref>. Statistical significance was tested by one-way ANOVA, and pairwise comparison was performed according to Tukey&#x2013;Kramer multiple comparison test. NS; <italic>p</italic>&#x2009;&#x003E;&#x2009;0.05; &#x002A;; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05; &#x002A;&#x002A;; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01; &#x002A;&#x002A;&#x002A;; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, (vs. 0 DIV). Data are presented as mean&#x2009;&#x00B1;&#x2009;SD, based on four independent experiments (<italic>n</italic>&#x2009;=&#x2009;4).</p>
</caption>
<graphic xlink:href="fnmol-15-1068990-g002.tif"/>
</fig>
<p>In a previous study, we showed that temporal changes in synaptic proteins in hippocampal slices indicate acute synaptic loss (0&#x2013;4 DIV), followed by synapse formation (4&#x2013;15 DIV) and maintenance (&#x003E;15 DIV) phases (<xref ref-type="bibr" rid="ref36">Muller et al., 1993</xref>; <xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>); therefore, in the current study, we used slices cultured at 0, 1, 4, 7, 14, 28, 42, and 56 DIV for further evaluation. We assessed the expression of markers for neurons, astrocytes, and microglia <italic>via</italic> immunoblotting analysis (<xref rid="fig2" ref-type="fig">Figures 2E</xref>&#x2013;<xref rid="fig2" ref-type="fig">I</xref>). Expression levels of &#x03B2;-actin and &#x03B2;III tubulin decreased immediately after cultivation and are stable after 4 DIV (Tukey&#x2019;s Multiple Comparison Test, <italic>p</italic> &#x003E;&#x2009;0.05, versus 4 DIV). These results indicate that the number of neurons decreased immediately after plating the hippocampal slice on a filter membrane cup and stabilized after 7&#x2009;days. However, the number of astrocytes and microglia increased 1 d after plating. The level of galectin-3, which is required for microglial activation in the injured brain (<xref ref-type="bibr" rid="ref33">Lalancette-H&#x00E9;bert et al., 2012</xref>), was elevated for 1&#x2009;week after preparation and then declined. PI assays showed that neural cells survived in 50 DIV cultures hippocampal slices (<xref ref-type="supplementary-material" rid="SM3">Supplementary Figure S3</xref>). These findings indicate that neural cells remained in the cultured hippocampal slices for over 8&#x2009;weeks.</p>
</sec>
<sec id="sec15">
<title>Alternative cleavage of APP</title>
<p>Previously, reorganization and maturation of neurons were reported in cultured hippocampal slices (<xref ref-type="bibr" rid="ref4">Buchs et al., 1993</xref>; <xref ref-type="bibr" rid="ref36">Muller et al., 1993</xref>). We evaluated the expression levels of BACE1, APP, and nicastrin using immunoblotting for several weeks. Our results indicated that their expression increased after 7&#x2009;days (<xref rid="fig3" ref-type="fig">Figures 3A</xref>&#x2013;<xref rid="fig3" ref-type="fig">C</xref>; <xref ref-type="supplementary-material" rid="SM2">Supplementary Figure S2</xref>). APP is cleaved by members of the &#x03B1;-or &#x03B2;-secretase family. &#x03B1;-Secretases are members of the ADAM family and are considered to be a part of the non-amyloidogenic pathway in APP processing (<xref ref-type="bibr" rid="ref45">Selkoe, 1991</xref>; <xref ref-type="bibr" rid="ref15">Hardy and Higgins, 1992</xref>). In accordance with previous reports (<xref ref-type="bibr" rid="ref48">Stachel et al., 2004</xref>), DAPT treatment increased the level of APP carboxyl-terminal fragment (APP-CTF). Mixture of &#x03B1;-, &#x03B2;-, and &#x03B3;-secretase inhibitors increased APP full-length (APP-FL) and abolished APP-CTF levels (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). Furthermore, we cultured hippocampal slices (14DIV) with fresh SCM containing vehicle (DMSO) or each inhibitor after washing three times with 1&#x2009;ml fresh SCM for 24&#x2009;h. Treatment with each secretase inhibitor increased immature and mature APP-FL due to the reduction of APP cleavage. Treatment with both inhibitors blocked almost all the first steps of APP cleavage, further increasing the amount of APP-FL (<xref rid="fig3" ref-type="fig">Figures 3E</xref>&#x2013;<xref rid="fig3" ref-type="fig">H</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Chronological analysis of APP and BACE1 by immunoblotting. Immunoblotting analysis of hippocampal slices (0&#x2013;56 days <italic>in vitro</italic>, DIV) using antibodies against BACE1 <bold>(A)</bold>, APP <bold>(B)</bold>, and GAPDH <bold>(C)</bold>. which was normalized to &#x03B2;-actin and relative to a 0 DIV sample. Each point (filled circle) denotes relative protein expression which was normalized to GAPDH and relative to a 0 DIV (acute slice) sample. Data were analyzed using one-way ANOVA, and pairwise comparison was performed according to Tukey&#x2013;Kramer multiple comparison test. NS; <italic>p</italic>&#x2009;&#x003E;&#x2009;0.05, <sup>&#x002A;</sup>; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup>; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, <sup>&#x002A;&#x002A;&#x002A;</sup>; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001 (vs. 0 DIV). Data are presented as mean&#x2009;&#x00B1;&#x2009;SD, based on four independent experiments (<italic>n</italic>&#x2009;=&#x2009;4). Full-length blots are shown in <xref ref-type="supplementary-material" rid="SM5">Supplementary Figure S5</xref>. <bold>(D&#x2013;H)</bold> Immunoblotting analysis of APP cleavage. <bold>(D)</bold> Cultured hippocampal slices (slice, 14DIV) or dissociated hippocampal cells (dissociated, 14DIV) treated with &#x03B3;-secretase inhibitor (DAPT, 10&#x2009;&#x03BC;M) or secretase inhibitor mix (MIX; 10&#x2009;&#x03BC;M DAPT, 50&#x2009;&#x03BC;M ADAM inhibitor (GI254023X), and 2&#x2009;&#x03BC;M BACE inhibitor (BACE inhibitor IV) for 24&#x2009;h. &#x03B2;-actin served as a loading control. APP-FL: full-length APP. APP-CTF: APP C-terminal fragment. <bold>(E&#x2013;H)</bold> Cultured hippocampal slices (14DIV, <italic>n</italic>&#x2009;=&#x2009;3) treated with an ADAM inhibitor (GI254023X, 50&#x2009;&#x03BC;M) and/or BACE1 inhibitor (BACE inhibitor IV, 2&#x2009;&#x03BC;M) for 24&#x2009;h. Mature APP-FL (mAPP) and immature APP-FL (imAPP) levels were evaluated quantitatively. Open bar, DMSO; stripe bar, BACE inhibitor; gray bar, ADAM inhibitor; black bar, BACE inhibitor and ADAM inhibitor mix. GAPDH served as a loading control. Full-length blots are shown in <xref ref-type="supplementary-material" rid="SM6">Supplementary Figure S6</xref>. Statistical significance was tested by one-way ANOVA, and pairwise comparison was performed according to Tukey&#x2013;Kramer multiple comparison test. NS; <italic>p</italic>&#x2009;&#x003E;&#x2009;0.05; <sup>&#x002A;</sup>; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05; <sup>&#x002A;&#x002A;</sup>; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.01; <sup>&#x002A;&#x002A;&#x002A;</sup>; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. Data are presented as mean&#x2009;&#x00B1;&#x2009;SD, based on three independent experiments (<italic>n</italic>&#x2009;=&#x2009;3).</p>
</caption>
<graphic xlink:href="fnmol-15-1068990-g003.tif"/>
</fig>
</sec>
<sec id="sec16">
<title>Biochemical analysis of A&#x03B2; production</title>
<p>Since organotypic cultures are artificial environments, we were able to control extracellular conditions, including temperature, oxygen content, nutritional factors, and neural activity. To elucidate the optimal conditions for the analysis of A&#x03B2; secretion, we examined the effect of the number of slices on the filter membrane cup and incubation period. Since reducing the number of slices in a cup allows for more efficient experiments, we plated 1 to 6 slices on a filter membrane cup for culture and incubated cultured slices with 1&#x2009;ml fresh SCM for 24&#x2009;h. We measured the total protein content of slices and A&#x03B2; in SCM from cultured hippocampal slices using a two-site ELISA assay (see Materials and Methods). The total protein content of the cultured hippocampal slice was 52.8&#x2009;&#x00B1;&#x2009;9.3&#x2009;&#x03BC;g. The correlation coefficient between A&#x03B2;<sub>40</sub> and slice number was R<sup>2</sup>&#x2009;=&#x2009;0.9607 (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001) (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). In accordance with previous reports, a single hippocampal slice secreted 75&#x2013;120&#x2009;pg A&#x03B2;<sub>40</sub> for 24&#x2009;h (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). Further analysis showed that the ratio of A&#x03B2;<sub>40</sub> secretion to total protein amount was 1.7 to 2.8&#x2009;pg/&#x03BC;g for 24&#x2009;h (<xref rid="fig4" ref-type="fig">Figure 4C</xref>). There was no significant difference in A&#x03B2;<sub>40</sub> secretion between groups (<italic>p</italic>&#x2009;&#x003E;&#x2009;0.05). To assess the incubation time for the A&#x03B2;<sub>40</sub> assay, we cultured four hippocampal slices for 1&#x2013;90&#x2009;h with fresh SCM after washing three times with 1&#x2009;ml fresh SCM. A statistically significant (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001) strong correlation (R<sup>2</sup>&#x2009;=&#x2009;0.9190) was observed between A&#x03B2;<sub>40</sub> secretion and the incubation time (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). Our time-lapse analysis of A&#x03B2; secretion showed that a single hippocampal slice secreted 2.68&#x2009;&#x00B1;&#x2009;0.82&#x2009;pg for 1&#x2009;h (<xref rid="fig4" ref-type="fig">Figure 4E</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Culture condition and period dependency of the secretion of A&#x03B2;<sub>40</sub>. <bold>(A)</bold> Total protein in the lysate from 1, 2, 4, or 6 hippocampal slices (filled circles). Dashed line; linear regression. <italic>R</italic><sup>2</sup>&#x2009;=&#x2009;0.9623, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001. <bold>(B)</bold> Quantification of A&#x03B2;<sub>40</sub> secreted from 1, 2, 4, or 6 cultured hippocampal slices (15&#x2009;days <italic>in vitro</italic>, DIV) for 24&#x2009;h (filled circles). Dashed line, linear regression of A&#x03B2;<sub>40</sub>. <italic>R</italic><sup>2</sup>&#x2009;=&#x2009;0.9607, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001. Quantification of A&#x03B2;<sub>42</sub> secreted from 4 cultured hippocampal slices (15&#x2009;days <italic>in vitro</italic>, DIV) for 24&#x2009;h (open square). Results are presented as mean&#x2009;&#x00B1;&#x2009;SD based on three independent experiments (<italic>n</italic>&#x2009;=&#x2009;3). <bold>(C)</bold> The ratio of A&#x03B2;<sub>40</sub> to total slice protein. Open bar, 1 slice; stripe bar, 2 slices; gray bar, 4 slices; black bar, 6 slices. Statistical significance was tested by one-way ANOVA, and pairwise comparison was performed according to Tukey&#x2013;Kramer multiple comparison test. There was no significant difference between groups, <italic>p</italic>&#x2009;&#x003E;&#x2009;0.05. <bold>(D)</bold> Quantification of A&#x03B2;<sub>40</sub> (filled circles) or A&#x03B2;<sub>42</sub> (open square) secreted from a cultured hippocampal slice (15&#x2013;21 DIV) for 1&#x2013;90&#x2009;h (A&#x03B2;<sub>40</sub>) or 24&#x2009;h (A&#x03B2;<sub>42</sub>). Results are presented as mean&#x2009;&#x00B1;&#x2009;SD based on four (1, 2, 3, 6, 12, 18&#x2009;h) or eight (24, 50, 90&#x2009;h) independent experiments (<italic>n</italic>&#x2009;=&#x2009;4 or 8). Dashed line, linear regression of A&#x03B2;<sub>40</sub>. <italic>R</italic><sup>2</sup>&#x2009;=&#x2009;0.9190, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001. <bold>(E)</bold> A&#x03B2;<sub>40</sub> secretion from a cultured hippocampal slice per 1&#x2009;h. The amount of A&#x03B2;<sub>40</sub> secretion is compensated for the residual medium (filled circle). Open square&#x2009;=&#x2009;an average of all dates (2.68&#x2009;&#x00B1;&#x2009;0.82&#x2009;pg/h, <italic>n</italic>&#x2009;=&#x2009;48, 1&#x2013;90&#x2009;h). <bold>(F,G)</bold> Chronological quantitative analysis of the secretion of A&#x03B2;<sub>42</sub> [<bold>(F)</bold>, open squares] or the ratio of A&#x03B2;<sub>42</sub> to A&#x03B2;<sub>40</sub> in SCM [<bold>(G)</bold>, open circles]. Four hippocampal slices were plated on a Millicell culture insert. For the A&#x03B2; assay, hippocampal slices were cultured with fresh SCM for 24&#x2009;h at 37&#x00B0;C. A&#x03B2;<sub>40</sub> and A&#x03B2;<sub>42</sub> were quantified using ELISA.</p>
</caption>
<graphic xlink:href="fnmol-15-1068990-g004.tif"/>
</fig>
</sec>
<sec id="sec17">
<title>Chronological analysis of A&#x03B2; production</title>
<p>We investigated whether the amount of A&#x03B2; secreted changed depending on the culture period. To quantify A&#x03B2; secretion levels, we collected SCM-cultured hippocampal slices (1&#x2013;58 DIV) for 24&#x2009;h after washing three times with 1&#x2009;ml fresh SCM. We previously reported that secretion of sAPP&#x03B2; was between 3 and 6&#x2009;ng/ml and secretion of A&#x03B2;<sub>40</sub> was between 200 and 300&#x2009;pg/ml during the monitoring period (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). A&#x03B2;<sub>40</sub> and A&#x03B2;<sub>42</sub> are the most common isoforms of A&#x03B2; in the brain and are the main components of amyloid plaques found in AD brains. Here, we measured A&#x03B2;<sub>42</sub> levels in the same SCM preparation using a two-site ELISA assay. The secretion of A&#x03B2;<sub>42</sub> was 23 to 50&#x2009;pg, and the ratio of A&#x03B2;<sub>42</sub> to A&#x03B2;<sub>40</sub> was 10 to 17% during the monitoring period (<xref rid="fig4" ref-type="fig">Figures 4F</xref>,<xref rid="fig4" ref-type="fig">G</xref>).</p>
</sec>
<sec id="sec18">
<title>Comparison of species differences in APP cleavage</title>
<p>To apply hippocampal slice culture in various research fields, we assessed the amount of A&#x03B2; secretion by comparing rats and mice. The amount of A&#x03B2;<sub>40</sub> secreted from cultured mouse hippocampal slices (15 DIV) was 160&#x2009;&#x00B1;&#x2009;15&#x2009;pg/ml for 24&#x2009;h (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). Although A&#x03B2; secreted from mouse hippocampus slices was less than that from rats (350&#x2009;&#x00B1;&#x2009;65&#x2009;pg/ml), there was no significant difference in A&#x03B2; secretion compared to the total protein content of slices (mice: 1.75&#x2009;&#x00B1;&#x2009;0.3&#x2009;pg/&#x03BC;g, rats: 1.86&#x2009;&#x00B1;&#x2009;0.3&#x2009;pg/&#x03BC;g, <xref rid="fig5" ref-type="fig">Figures 5B</xref>,<xref rid="fig5" ref-type="fig">C</xref>). APP is commonly cleaved by &#x03B1;-or &#x03B2;-secretase; both remove and release nearly the entire extracellular domain, referred to as sAPP (sAPP&#x03B1; and sAPP&#x03B2;). This alternative cleavage is critical for elucidating the molecular mechanisms underlying AD pathology. We revealed that both sAPP&#x03B1; and sAPP&#x03B2; are secreted from hippocampal slice cultures using the sAPP assay. The amount of secretion of sAPP&#x03B1; and sAPP&#x03B2; from four cultured rat hippocampal slices was 1.30&#x2009;&#x00B1;&#x2009;0.12 and 0.63&#x2009;&#x00B1;&#x2009;0.11&#x2009;ng, respectively. The amount of secretion of sAPP&#x03B1; and sAPP&#x03B2; from four cultured mouse hippocampal slices was 0.69&#x2009;&#x00B1;&#x2009;0.05 and 0.44&#x2009;&#x00B1;&#x2009;0.01&#x2009;ng, respectively (<xref rid="fig5" ref-type="fig">Figures 5D</xref>,<xref rid="fig5" ref-type="fig">E</xref>). These results indicated that &#x03B1; cleavage was dominant, similar to that in the model animal.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>APP cleavage products from cultured mouse and rat hippocampal slices. A&#x03B2;<sub>40</sub>, sAPP&#x03B1;, and sAPP&#x03B2; in SCM were quantified using ELISA. Four hippocampal slices were prepared from rats or mice plated on a filter membrane cup. <bold>(A)</bold> Quantification of A&#x03B2;<sub>40</sub> secreted from hippocampal slices (15&#x2009;days <italic>in vitro</italic>) cultured with fresh SCM for 24&#x2009;h at 37&#x00B0;C. <bold>(B)</bold> Total protein levels in rat and mouse hippocampal slices. <bold>(C)</bold> Calculated data for the ratio of A&#x03B2;<sub>40</sub> to total protein ratio. <bold>(D,E)</bold> Quantification of sAPP&#x03B1; and sAPP&#x03B2; secreted from hippocampal slices cultured in fresh SCM for 24&#x2009;h at 37&#x00B0;C. Statistical significance was determined using unpaired <italic>t</italic>-tests. NS; <italic>p</italic>&#x2009;&#x003E;&#x2009;0.05; &#x002A;; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05; &#x002A;&#x002A;&#x002A;; <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. Data are presented as mean&#x2009;&#x00B1;&#x2009;SD, based on three independent cultures (<italic>n</italic>&#x2009;=&#x2009;3).</p>
</caption>
<graphic xlink:href="fnmol-15-1068990-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="sec19" sec-type="discussions">
<title>Discussion</title>
<p>Herein, we present a method for preparing hippocampal slice cultures and consecutive analyses of APP processing. In this study, we sliced the hippocampus to a thickness of 400&#x2009;&#x03BC;m. In many studies using brain organotypic cultures, the brain was sliced at 250&#x2013;400&#x2009;&#x03BC;m thick (<xref ref-type="bibr" rid="ref49">Stoppini et al., 1991</xref>; <xref ref-type="bibr" rid="ref50">Tominaga-Yoshino et al., 2002</xref>; <xref ref-type="bibr" rid="ref53">Uesaka et al., 2012</xref>; <xref ref-type="bibr" rid="ref18">Humpel, 2015</xref>). When thicker slices, such as 600 or 700&#x2009;&#x03BC;m, are used, refluxing of the culture medium is required (<xref ref-type="bibr" rid="ref39">Rambani et al., 2009</xref>), and fewer slices can be made from the hippocampus. Stable results were obtained by culturing four to five 400&#x2009;&#x03BC;m thick slices in one cup and analyzing them together (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Cultured hippocampal slices preserve the tissue architecture, neural circuits, and synaptic dynamics (<xref ref-type="bibr" rid="ref49">Stoppini et al., 1991</xref>; <xref ref-type="bibr" rid="ref4">Buchs et al., 1993</xref>; <xref ref-type="bibr" rid="ref36">Muller et al., 1993</xref>). Because of individual differences and the difficulty of manipulation in animal models, comparative analyses before and after administration of the same preparation are not accessible. However, to evaluate drug efficacy, this comparative analysis before and after administration of the same culture preparation is meaningful. As primary dissociated neural cultures are vulnerable to drug washout during medium changes, a comparative study using the same preparation is extremely difficult. Filter membrane cups allow easy handling of preparations; therefore, we were able to collect and change the culture media without da mage and perform comparative analyses using the same preparations (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Because the membrane cup is designed for disposable use, slice culture is costly. The use of self-made devices and filter membranes can reduce costs (<xref ref-type="bibr" rid="ref31">Koyama et al., 2007</xref>).</p>
<p>Here, we showed the existence of microglia, astrocytes, and neurons in slices cultured for 2 months (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Our chronological immunoblotting analysis indicated that glial cells proliferated for 1&#x2013;2&#x2009;weeks and were then maintained for several weeks (<xref rid="fig2" ref-type="fig">Figure 2G</xref>). In addition, the level of galectin-3, which is required for microglial activation and proliferation in the injured brain (<xref ref-type="bibr" rid="ref33">Lalancette-H&#x00E9;bert et al., 2012</xref>), was elevated for a week after preparation and then declined (<xref rid="fig2" ref-type="fig">Figure 2I</xref>). The expression patterns of APP and BACE1 in cultured hippocampal slices accumulated at the stratum radiatum, similar to the <italic>in vivo</italic> distribution (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>). The expression levels of the synapse marker proteins synaptophysin and PSD95 decreased from 1 to 4&#x2009;days and increased after 7&#x2009;days (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). Since synapses and neural circuits have formed and matured after 14DIV(<xref ref-type="bibr" rid="ref36">Muller et al., 1993</xref>; <xref ref-type="bibr" rid="ref50">Tominaga-Yoshino et al., 2002</xref>), quantitative analysis indicates that APP and BACE1 expression levels are stable (Tukey&#x2019;s Multiple Comparison Test, <italic>p</italic> &#x003E;&#x2009;0.05, versus 14DIV, <xref rid="fig3" ref-type="fig">Figures 3A</xref>&#x2013;<xref rid="fig3" ref-type="fig">C</xref>). Similar to previous studies (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>), immunoblotting analysis indicated that the electrophoretic mobility of BACE1 changed slightly after 4 DIV, which may represent the effect of the BACE1 maturation process. The newly synthesized BACE1 is cleaved at its prodomain before being transported to the trans-Golgi network (<xref ref-type="bibr" rid="ref1">Benjannet et al., 2001</xref>). Further analysis of BACE1 intracellular localization is required; however, A&#x03B2; production is determined not only by BACE1 expression and enzyme activity but also by &#x03B1;-secretase and &#x03B3;-secretase activity. Our results indicate that slices cultured for 2 or 3&#x2009;weeks are suitable for analyzing neural functions and APP processing. We evaluated the differences between the slices and dissociated cultures; DAPT treatment accumulated APP-CTF to the same extent in both dissociated and slice cultures (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). The &#x03B1;-secretase family of proteins alternatively cleaves APP within the A&#x03B2; sequence. Thus, &#x03B1;-cleavage precludes A&#x03B2; formation and is considered part of the non-amyloidogenic pathway in APP processing (<xref ref-type="bibr" rid="ref34">Lammich et al., 1999</xref>). In cultured hippocampal slices, alternative cleavage of APP is conserved (<xref rid="fig3" ref-type="fig">Figures 3F</xref>&#x2013;<xref rid="fig3" ref-type="fig">H</xref>); thus, the application of the &#x03B1;-secretase inhibitor increases the secretion of A&#x03B2; (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). On the other hand, the ratio of mature APP-FL (mAPP) to immature APP-FL (imAPP) was not altered by secretase inhibitor treatment (<xref rid="fig3" ref-type="fig">Figure 3H</xref>). This result indicates that secretase activity does not affect APP maturation. Secretase inhibition may result in accumulation of only mAPP or both mAPP and imAPP. Further investigation is needed to explain why secretase inhibition increases both mature and immature forms of APP. Since secretases are required for neuronal growth and maturation (<xref ref-type="bibr" rid="ref10">Chow et al., 2010</xref>), inhibition of both secretases could have adversely affected neurons and reduced GAPDH expression (<xref rid="fig3" ref-type="fig">Figure 3E</xref>). Western blotting is at best a semi-quantitative method and dependent upon the proper choice of loading controls. Long-term incubation may alter the expression levels of &#x03B2;-actin and GAPDH, which are generally considered loading controls. Therefore, further study is needed to compare different culture periods. In this report, immunostaining of slice cultures was performed to confirm the survival of neurons and glial cells and their distribution over a 2-month period.</p>
<p>A&#x03B2; is formed after the sequential cleavage of APP by &#x03B2;-and &#x03B3;-secretase, which accumulates in the central nervous system and subsequently initiates neural dysfunction. Excessive accumulation of A&#x03B2; results in aggregation and amyloid deposition in the brains of AD patients (<xref ref-type="bibr" rid="ref3">Blennow et al., 2006</xref>). &#x03B3;-Secretase cleaves within the transmembrane region of APP and can generate several isoforms of 30&#x2013;51 amino acid residues in length (<xref ref-type="bibr" rid="ref38">Olsson et al., 2014</xref>). A&#x03B2;<sub>40</sub> and A&#x03B2;<sub>42</sub> are the most common isoforms of A&#x03B2; in the brain and are the main components of amyloid plaques found in AD brains. Since the pathological changes of AD progress slowly, a model for continuously analyzing central nervous function for an extended period is required. This study evaluated a method to continuously investigate A&#x03B2; formation using cultured hippocampal slices. To estimate A&#x03B2; production, we measured A&#x03B2;<sub>40</sub> and A&#x03B2;<sub>42</sub> secretion from hippocampal slices using a two-site ELISA assay. In the culture medium, four hippocampal slices secreted 200&#x2013;400&#x2009;pg A&#x03B2;<sub>40</sub> and 23&#x2013;50&#x2009;pg A&#x03B2;<sub>42</sub> for 24&#x2009;h (<xref ref-type="bibr" rid="ref27">Kamikubo et al., 2017</xref>). These data indicated that 2.0&#x2013;4.0&#x2009;pg A&#x03B2;<sub>40</sub> and 0.2&#x2013;0.5&#x2009;pg A&#x03B2;<sub>42</sub> were secreted by a cultured hippocampal slice in 1&#x2009;h. According to previous reports (<xref ref-type="bibr" rid="ref25">Kamenetz et al., 2003</xref>), the ratio of A&#x03B2;<sub>42</sub> to A&#x03B2;<sub>40</sub> is between 10 and 17% (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Neurodegenerative diseases are well characterized in primary cultures of rats or mice. However, differences between species are rarely analyzed. We, therefore, evaluated APP processing in hippocampal slice cultures from these rodents. Examination of the differences between species revealed no difference between the amount of A&#x03B2;<sub>40</sub> and sAPP secretion in mouse and rat hippocampal slices (<xref rid="fig5" ref-type="fig">Figure 5</xref>). Cultured rodent hippocampal slices are useful for analyzing APP processing. The A&#x03B2;<sub>40</sub> form is the most common of the two; however, human A&#x03B2;<sub>42</sub> is more fibrillogenic and is thus associated with disease states (<xref ref-type="bibr" rid="ref58">Yin et al., 2007</xref>). Since rodent A&#x03B2; is poorly aggregated (<xref ref-type="bibr" rid="ref24">Jankowsky et al., 2007</xref>), cultured hippocampal slices are not a good platform for analyzing A&#x03B2; aggregation and accumulation. The addition of chemically synthesized or recombinant human A&#x03B2; should be used to analyze the regulation of endogenous A&#x03B2; production by using antibodies specific to mouse/rat A&#x03B2;.</p>
<p>Furthermore, we attempted to optimize the incubation period and number of slices for the analysis of A&#x03B2;. We placed 1 to 6 hippocampal slices on a membrane cup for 1 week of culture and incubated these slices for 24&#x2009;h with fresh SCM for the A&#x03B2; assay. A&#x03B2; concentration increased linearly with the number of cultured slices (<xref rid="fig4" ref-type="fig">Figure 4</xref>). For time-lapse analysis of A&#x03B2; secretion, we cultured four hippocampal slices and incubated them for 1&#x2013;90&#x2009;h with fresh SCM after washing three times with 1&#x2009;ml fresh SCM. Our results indicate that a single hippocampal slice secreted 2.68&#x2009;&#x00B1;&#x2009;0.82&#x2009;pg for 1&#x2009;h (<xref rid="fig4" ref-type="fig">Figures 4B</xref>,<xref rid="fig4" ref-type="fig">C</xref>). The dispersion of the A&#x03B2; assay indicated that the carryover medium significantly affected the measurement results with short-term incubation. When many slices are placed on a membrane cup, it is possible to analyze A&#x03B2; production, but proper placement of slices is difficult. We suggest that it is appropriate to incubate 2 to 6 hippocampal slices in a membrane cup.</p>
<p>Slice cultures are usually derived from early postnatal or embryonic rodents. Because an essential cytoarchitecture has already been established, neural circuits are still immature, and early postnatal periods (days 0 to 10) are ideally suited for culturing. Some attempts have been made to culture adult tissues of animal models to elucidate age-related neurodegenerative diseases (<xref ref-type="bibr" rid="ref35">Mewes et al., 2012</xref>). Slice cultures have been used in various research fields, including physiology, pharmacology, endocrinology, biochemistry, and development of pathology (<xref ref-type="bibr" rid="ref21">Ikegaya, 1999</xref>; <xref ref-type="bibr" rid="ref18">Humpel, 2015</xref>; <xref ref-type="bibr" rid="ref16">Hiragi et al., 2017</xref>; <xref ref-type="bibr" rid="ref40">Richter et al., 2020</xref>). Since rodent A&#x03B2; has low aggregation properties, it is possible to analyze A&#x03B2; aggregation and toxicity by exogenous administration of human A&#x03B2;, which has high aggregation properties. Other groups have been able to reproduce pathological protein aggregates deposition by injection seed of A&#x03B2; aggregates, &#x03B1;-synuclein aggregates, or extracts from the brains of patients with neurodegenerative diseases (<xref ref-type="bibr" rid="ref57">Wu et al., 2020</xref>). We cultured hippocampal slices for several months using the methods described in previous reports (<xref ref-type="bibr" rid="ref26">Kamikubo et al., 2006</xref>, <xref ref-type="bibr" rid="ref27">2017</xref>). Using slice cultures of hippocampi derived from early-onset models of neurodegenerative diseases (<xref ref-type="bibr" rid="ref41">Saito et al., 2014</xref>; <xref ref-type="bibr" rid="ref37">Novotny et al., 2016</xref>; <xref ref-type="bibr" rid="ref44">Scheiblich et al., 2021</xref>), we can reveal the early processes of these diseases. The use of brain slice cultures of wild-type rodents to construct a model of neurodegenerative diseases may avoid the compensatory mechanism of genetic modification. Furthermore, by using cultured brain slices, we can analyze embryonically lethal genetic modifications. Specific cells can be removed from cultured hippocampal slices with drug administration (<xref ref-type="bibr" rid="ref55">Vinet et al., 2012</xref>; <xref ref-type="bibr" rid="ref40">Richter et al., 2020</xref>). Co-culturing slices from the brains of mice with distinct genetic modifications enables analyses that are not feasible <italic>in vivo</italic> (<xref ref-type="bibr" rid="ref53">Uesaka et al., 2012</xref>, <xref ref-type="bibr" rid="ref52">2018</xref>). Brain organ culture only applies to analyzing a limited number of brain regions, making diagnosing neurodegenerative diseases in a wide range of brain regions challenging. We anticipate that hippocampal slice culture can be used as an <italic>ex vivo</italic> model to reveal the molecular and cellular basis of neuropsychiatric disorders.</p>
<p>This study provides a method for consecutive analysis of protein secretion from brain slices to study neurodegenerative diseases. Hippocampal slice culture is an experimental system that effectively maintains the <italic>in vivo</italic> neuronal network and is a convenient method to study the cellular and molecular mechanisms underlying neuropsychiatric disorders, including AD, and to evaluate therapeutic approaches for such diseases.</p>
</sec>
<sec id="sec20" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="sec21">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by Animal Experimentation Committee of Juntendo University.</p>
</sec>
<sec id="sec22">
<title>Author contributions</title>
<p>YK conceived and designed the study and wrote and reviewed the manuscript. YK, YZ, HJ, KN, YH, and NT contributed to investigation and data analysis. YK and TS supervised the study. All the authors approved the final version of the manuscript.</p>
</sec>
<sec id="sec23" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by JSPS KAKENHI Grant Numbers JP20K07765 and JP17K09040 (to YK) and grants-in-aid from the TERUMO LIFE SCIENCE FOUNDATION (to YK).</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>We would like to thank the Laboratory of Proteomics and Biomolecular Science, Morphology and Image Analytics, and Biomedical Research Resources, Research Support Center, Juntendo University Graduate School of Medicine, for providing technical assistance.</p>
</ack>
<sec id="sec25" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2022.1068990/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnmol.2022.1068990/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.TIF" id="SM1" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_2.TIF" id="SM2" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_3.TIF" id="SM3" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_4.TIF" id="SM4" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_5.TIF" id="SM5" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_6.TIF" id="SM6" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_7.TIF" id="SM7" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image_8.TIF" id="SM8" mimetype="image/tif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benjannet</surname> <given-names>S.</given-names></name> <name><surname>Elagoz</surname> <given-names>A.</given-names></name> <name><surname>Wickham</surname> <given-names>L.</given-names></name> <name><surname>Mamarbachi</surname> <given-names>M.</given-names></name> <name><surname>Munzer</surname> <given-names>J. S.</given-names></name> <name><surname>Basak</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro-and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production</article-title>. <source>J. Biol. Chem.</source> <volume>276</volume>, <fpage>10879</fpage>&#x2013;<lpage>10887</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M009899200</pub-id>, PMID: <pub-id pub-id-type="pmid">11152688</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergold</surname> <given-names>P. J.</given-names></name> <name><surname>Casaccia-Bonnefil</surname> <given-names>P.</given-names></name> <name><surname>Zeng</surname> <given-names>X. L.</given-names></name> <name><surname>Federoff</surname> <given-names>H. J.</given-names></name></person-group> (<year>1993</year>). <article-title>Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>90</volume>, <fpage>6165</fpage>&#x2013;<lpage>6169</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.90.13.6165</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blennow</surname> <given-names>K.</given-names></name> <name><surname>De Leon</surname> <given-names>M. J.</given-names></name> <name><surname>Zetterberg</surname> <given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Alzheimer's disease</article-title>. <source>Lancet</source> <volume>368</volume>, <fpage>387</fpage>&#x2013;<lpage>403</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(06)69113-7</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buchs</surname> <given-names>P. A.</given-names></name> <name><surname>Stoppini</surname> <given-names>L.</given-names></name> <name><surname>Muller</surname> <given-names>D.</given-names></name></person-group> (<year>1993</year>). <article-title>Structural modifications associated with synaptic development in area CA1 of rat hippocampal organotypic cultures</article-title>. <source>Brain Res. Dev. Brain Res.</source> <volume>71</volume>, <fpage>81</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0165-3806(93)90108-M</pub-id>, PMID: <pub-id pub-id-type="pmid">8432003</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caruso</surname> <given-names>G.</given-names></name> <name><surname>Spampinato</surname> <given-names>S. F.</given-names></name> <name><surname>Cardaci</surname> <given-names>V.</given-names></name> <name><surname>Caraci</surname> <given-names>F.</given-names></name> <name><surname>Sortino</surname> <given-names>M. A.</given-names></name> <name><surname>Merlo</surname> <given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Beta-amyloid and Oxidative stress: perspectives in drug development</article-title>. <source>Curr. Pharm. Des.</source> <volume>25</volume>, <fpage>4771</fpage>&#x2013;<lpage>4781</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1381612825666191209115431</pub-id>, PMID: <pub-id pub-id-type="pmid">31814548</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chasseigneaux</surname> <given-names>S.</given-names></name> <name><surname>Allinquant</surname> <given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Functions of Abeta, sAPPalpha and sAPPbeta: similarities and differences</article-title>. <source>J. Neurochem.</source> <volume>120</volume>, <fpage>99</fpage>&#x2013;<lpage>108</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07584.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22150401</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>S.</given-names></name> <name><surname>Wood</surname> <given-names>A.</given-names></name> <name><surname>Bowlby</surname> <given-names>M. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics</article-title>. <source>Curr. Neuropharmacol.</source> <volume>5</volume>, <fpage>19</fpage>&#x2013;<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.2174/157015907780077105</pub-id>, PMID: <pub-id pub-id-type="pmid">18615151</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname> <given-names>V. W.</given-names></name> <name><surname>Mattson</surname> <given-names>M. P.</given-names></name> <name><surname>Wong</surname> <given-names>P. C.</given-names></name> <name><surname>Gleichmann</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>An overview of APP processing enzymes and products</article-title>. <source>NeuroMolecular Med.</source> <volume>12</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12017-009-8104-z</pub-id>, PMID: <pub-id pub-id-type="pmid">20232515</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cline</surname> <given-names>E. N.</given-names></name> <name><surname>Bicca</surname> <given-names>M. A.</given-names></name> <name><surname>Viola</surname> <given-names>K. L.</given-names></name> <name><surname>Klein</surname> <given-names>W. L.</given-names></name></person-group> (<year>2018</year>). <article-title>The amyloid-beta oligomer hypothesis: beginning of the third decade</article-title>. <source>J. Alzheimers Dis.</source> <volume>64</volume>, <fpage>S567</fpage>&#x2013;<lpage>S610</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-179941</pub-id>, PMID: <pub-id pub-id-type="pmid">29843241</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Strooper</surname> <given-names>B.</given-names></name> <name><surname>Annaert</surname> <given-names>W.</given-names></name></person-group> (<year>2000</year>). <article-title>Proteolytic processing and cell biological functions of the amyloid precursor protein</article-title>. <source>J. Cell Sci.</source> <volume>113</volume>, <fpage>1857</fpage>&#x2013;<lpage>1870</lpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.113.11.1857</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>G&#x00E4;hwiler</surname> <given-names>B. H.</given-names></name> <name><surname>Capogna</surname> <given-names>M.</given-names></name> <name><surname>Debanne</surname> <given-names>D.</given-names></name> <name><surname>Mckinney</surname> <given-names>R. A.</given-names></name> <name><surname>Thompson</surname> <given-names>S. M.</given-names></name></person-group> (<year>1997</year>). <article-title>Organotypic slice cultures: a technique has come of age</article-title>. <source>Trends Neurosci.</source> <volume>20</volume>, <fpage>471</fpage>&#x2013;<lpage>477</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0166-2236(97)01122-3</pub-id>, PMID: <pub-id pub-id-type="pmid">9347615</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname> <given-names>J.</given-names></name> <name><surname>Selkoe</surname> <given-names>D. J.</given-names></name></person-group> (<year>2002</year>). <article-title>The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</article-title>. <source>Science</source> <volume>297</volume>, <fpage>353</fpage>&#x2013;<lpage>356</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1072994</pub-id>, PMID: <pub-id pub-id-type="pmid">12130773</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname> <given-names>J. A.</given-names></name> <name><surname>Higgins</surname> <given-names>G. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Alzheimer's disease: the amyloid cascade hypothesis</article-title>. <source>Science</source> <volume>256</volume>, <fpage>184</fpage>&#x2013;<lpage>185</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1566067</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiragi</surname> <given-names>T.</given-names></name> <name><surname>Andoh</surname> <given-names>M.</given-names></name> <name><surname>Araki</surname> <given-names>T.</given-names></name> <name><surname>Shirakawa</surname> <given-names>T.</given-names></name> <name><surname>Ono</surname> <given-names>T.</given-names></name> <name><surname>Koyama</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Differentiation of human induced pluripotent stem cell (hiPSC)-derived neurons in mouse hippocampal slice cultures</article-title>. <source>Front. Cell. Neurosci.</source> <volume>11</volume>:<fpage>143</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fncel.2017.00143</pub-id>, PMID: <pub-id pub-id-type="pmid">28567004</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hol</surname> <given-names>E. M.</given-names></name> <name><surname>Pekny</surname> <given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system</article-title>. <source>Curr. Opin. Cell Biol.</source> <volume>32</volume>, <fpage>121</fpage>&#x2013;<lpage>130</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ceb.2015.02.004</pub-id>, PMID: <pub-id pub-id-type="pmid">25726916</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Humpel</surname> <given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Organotypic brain slice cultures: a review</article-title>. <source>Neuroscience</source> <volume>305</volume>, <fpage>86</fpage>&#x2013;<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.07.086</pub-id>, PMID: <pub-id pub-id-type="pmid">26254240</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname> <given-names>B. T.</given-names></name> <name><surname>Van Hoesen</surname> <given-names>G. W.</given-names></name> <name><surname>Damasio</surname> <given-names>A. R.</given-names></name> <name><surname>Barnes</surname> <given-names>C. L.</given-names></name></person-group> (<year>1984</year>). <article-title>Alzheimer's disease: cell-specific pathology isolates the hippocampal formation</article-title>. <source>Science</source> <volume>225</volume>, <fpage>1168</fpage>&#x2013;<lpage>1170</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.6474172</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ichikawa-Tomikawa</surname> <given-names>N.</given-names></name> <name><surname>Ogawa</surname> <given-names>J.</given-names></name> <name><surname>Douet</surname> <given-names>V.</given-names></name> <name><surname>Xu</surname> <given-names>Z.</given-names></name> <name><surname>Kamikubo</surname> <given-names>Y.</given-names></name> <name><surname>Sakurai</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Laminin &#x03B1;1 is essential for mouse cerebellar development</article-title>. <source>Matrix Biol.</source> <volume>31</volume>, <fpage>17</fpage>&#x2013;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.matbio.2011.09.002</pub-id>, PMID: <pub-id pub-id-type="pmid">21983115</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikegaya</surname> <given-names>Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Abnormal targeting of developing hippocampal mossy fibers after epileptiform activities via L-type Ca2+ channel activation in vitro</article-title>. <source>J. Neurosci.</source> <volume>19</volume>, <fpage>802</fpage>&#x2013;<lpage>812</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-02-00802.1999</pub-id>, PMID: <pub-id pub-id-type="pmid">9880600</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname> <given-names>Y.</given-names></name> <name><surname>Ibata</surname> <given-names>I.</given-names></name> <name><surname>Ito</surname> <given-names>D.</given-names></name> <name><surname>Ohsawa</surname> <given-names>K.</given-names></name> <name><surname>Kohsaka</surname> <given-names>S.</given-names></name></person-group> (<year>1996</year>). <article-title>A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>224</volume>, <fpage>855</fpage>&#x2013;<lpage>862</lpage>. doi: <pub-id pub-id-type="doi">10.1006/bbrc.1996.1112</pub-id>, PMID: <pub-id pub-id-type="pmid">8713135</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irie</surname> <given-names>F.</given-names></name> <name><surname>Badie-Mahdavi</surname> <given-names>H.</given-names></name> <name><surname>Yamaguchi</surname> <given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>109</volume>, <fpage>5052</fpage>&#x2013;<lpage>5056</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1117881109</pub-id>, PMID: <pub-id pub-id-type="pmid">22411800</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jankowsky</surname> <given-names>J. L.</given-names></name> <name><surname>Younkin</surname> <given-names>L. H.</given-names></name> <name><surname>Gonzales</surname> <given-names>V.</given-names></name> <name><surname>Fadale</surname> <given-names>D. J.</given-names></name> <name><surname>Slunt</surname> <given-names>H. H.</given-names></name> <name><surname>Lester</surname> <given-names>H. A.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Rodent a beta modulates the solubility and distribution of amyloid deposits in transgenic mice</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume>, <fpage>22707</fpage>&#x2013;<lpage>22720</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M611050200</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamenetz</surname> <given-names>F.</given-names></name> <name><surname>Tomita</surname> <given-names>T.</given-names></name> <name><surname>Hsieh</surname> <given-names>H.</given-names></name> <name><surname>Seabrook</surname> <given-names>G.</given-names></name> <name><surname>Borchelt</surname> <given-names>D.</given-names></name> <name><surname>Iwatsubo</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>APP processing and synaptic function</article-title>. <source>Neuron</source> <volume>37</volume>, <fpage>925</fpage>&#x2013;<lpage>937</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00124-7</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamikubo</surname> <given-names>Y.</given-names></name> <name><surname>Egashira</surname> <given-names>Y.</given-names></name> <name><surname>Tanaka</surname> <given-names>T.</given-names></name> <name><surname>Shinoda</surname> <given-names>Y.</given-names></name> <name><surname>Tominaga-Yoshino</surname> <given-names>K.</given-names></name> <name><surname>Ogura</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Long-lasting synaptic loss after repeated induction of LTD: independence to the means of LTD induction</article-title>. <source>Eur. J. Neurosci.</source> <volume>24</volume>, <fpage>1606</fpage>&#x2013;<lpage>1616</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.05032.x</pub-id>, PMID: <pub-id pub-id-type="pmid">17004924</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamikubo</surname> <given-names>Y.</given-names></name> <name><surname>Takasugi</surname> <given-names>N.</given-names></name> <name><surname>Niisato</surname> <given-names>K.</given-names></name> <name><surname>Hashimoto</surname> <given-names>Y.</given-names></name> <name><surname>Sakurai</surname> <given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Consecutive analysis of BACE1 function on developing and developed neuronal cells</article-title>. <source>J. Alzheimers Dis.</source> <volume>56</volume>, <fpage>641</fpage>&#x2013;<lpage>653</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-160806</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamikubo</surname> <given-names>Y.</given-names></name> <name><surname>Wakisaka</surname> <given-names>K.</given-names></name> <name><surname>Imai</surname> <given-names>Y.</given-names></name> <name><surname>Sakurai</surname> <given-names>T.</given-names></name></person-group> (<year>2021</year>). <article-title>Midbrain slice culture as an ex vivo analysis platform for Parkinson's disease</article-title>. <source>Methods Mol. Biol.</source> <volume>2322</volume>, <fpage>111</fpage>&#x2013;<lpage>117</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-0716-1495-2_11</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kandalepas</surname> <given-names>P. C.</given-names></name> <name><surname>Sadleir</surname> <given-names>K. R.</given-names></name> <name><surname>Eimer</surname> <given-names>W. A.</given-names></name> <name><surname>Zhao</surname> <given-names>J.</given-names></name> <name><surname>Nicholson</surname> <given-names>D. A.</given-names></name> <name><surname>Vassar</surname> <given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>The Alzheimer's beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques</article-title>. <source>Acta Neuropathol.</source> <volume>126</volume>, <fpage>329</fpage>&#x2013;<lpage>352</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-013-1152-3</pub-id>, PMID: <pub-id pub-id-type="pmid">23820808</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaneshiro</surname> <given-names>N.</given-names></name> <name><surname>Komai</surname> <given-names>M.</given-names></name> <name><surname>Imaoka</surname> <given-names>R.</given-names></name> <name><surname>Ikeda</surname> <given-names>A.</given-names></name> <name><surname>Kamikubo</surname> <given-names>Y.</given-names></name> <name><surname>Saito</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer's disease</article-title>. <source>iScience</source> <volume>25</volume>:<fpage>103869</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.isci.2022.103869</pub-id>, PMID: <pub-id pub-id-type="pmid">35243232</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koyama</surname> <given-names>R.</given-names></name> <name><surname>Muramatsu</surname> <given-names>R.</given-names></name> <name><surname>Sasaki</surname> <given-names>T.</given-names></name> <name><surname>Kimura</surname> <given-names>R.</given-names></name> <name><surname>Ueyama</surname> <given-names>C.</given-names></name> <name><surname>Tamura</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>A low-cost method for brain slice cultures</article-title>. <source>J. Pharmacol. Sci.</source> <volume>104</volume>, <fpage>191</fpage>&#x2013;<lpage>194</lpage>. doi: <pub-id pub-id-type="doi">10.1254/jphs.SC0070119</pub-id>, PMID: <pub-id pub-id-type="pmid">17558179</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kreiner</surname> <given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?</article-title> <source>Front. Cell. Neurosci.</source> <volume>9</volume>:<fpage>56</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fncel.2015.00056</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lalancette-H&#x00E9;bert</surname> <given-names>M.</given-names></name> <name><surname>Swarup</surname> <given-names>V.</given-names></name> <name><surname>Beaulieu</surname> <given-names>J. M.</given-names></name> <name><surname>Bohacek</surname> <given-names>I.</given-names></name> <name><surname>Abdelhamid</surname> <given-names>E.</given-names></name> <name><surname>Weng</surname> <given-names>Y. C.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury</article-title>. <source>J. Neurosci.</source> <volume>32</volume>, <fpage>10383</fpage>&#x2013;<lpage>10395</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1498-12.2012</pub-id>, PMID: <pub-id pub-id-type="pmid">22836271</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lammich</surname> <given-names>S.</given-names></name> <name><surname>Kojro</surname> <given-names>E.</given-names></name> <name><surname>Postina</surname> <given-names>R.</given-names></name> <name><surname>Gilbert</surname> <given-names>S.</given-names></name> <name><surname>Pfeiffer</surname> <given-names>R.</given-names></name> <name><surname>Jasionowski</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>96</volume>, <fpage>3922</fpage>&#x2013;<lpage>3927</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.96.7.3922</pub-id>, PMID: <pub-id pub-id-type="pmid">10097139</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mewes</surname> <given-names>A.</given-names></name> <name><surname>Franke</surname> <given-names>H.</given-names></name> <name><surname>Singer</surname> <given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies</article-title>. <source>PLoS One</source> <volume>7</volume>:<fpage>e45017</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0045017</pub-id>, PMID: <pub-id pub-id-type="pmid">22984603</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname> <given-names>D.</given-names></name> <name><surname>Buchs</surname> <given-names>P. A.</given-names></name> <name><surname>Stoppini</surname> <given-names>L.</given-names></name></person-group> (<year>1993</year>). <article-title>Time course of synaptic development in hippocampal organotypic cultures</article-title>. <source>Brain Res. Dev. Brain Res.</source> <volume>71</volume>, <fpage>93</fpage>&#x2013;<lpage>100</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0165-3806(93)90109-N</pub-id>, PMID: <pub-id pub-id-type="pmid">8432004</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Novotny</surname> <given-names>R.</given-names></name> <name><surname>Langer</surname> <given-names>F.</given-names></name> <name><surname>Mahler</surname> <given-names>J.</given-names></name> <name><surname>Skodras</surname> <given-names>A.</given-names></name> <name><surname>Vlachos</surname> <given-names>A.</given-names></name> <name><surname>Wegenast-Braun</surname> <given-names>B. M.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Conversion of synthetic Abeta to <italic>in vivo</italic> active seeds and amyloid plaque formation in a hippocampal slice culture model</article-title>. <source>J. Neurosci.</source> <volume>36</volume>, <fpage>5084</fpage>&#x2013;<lpage>5093</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0258-16.2016</pub-id>, PMID: <pub-id pub-id-type="pmid">27147660</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname> <given-names>F.</given-names></name> <name><surname>Schmidt</surname> <given-names>S.</given-names></name> <name><surname>Althoff</surname> <given-names>V.</given-names></name> <name><surname>Munter</surname> <given-names>L. M.</given-names></name> <name><surname>Jin</surname> <given-names>S.</given-names></name> <name><surname>Rosqvist</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Characterization of intermediate steps in amyloid beta (A&#x03B2;) production under near-native conditions</article-title>. <source>J. Biol. Chem.</source> <volume>289</volume>, <fpage>1540</fpage>&#x2013;<lpage>1550</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M113.498246</pub-id>, PMID: <pub-id pub-id-type="pmid">24225948</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rambani</surname> <given-names>K.</given-names></name> <name><surname>Vukasinovic</surname> <given-names>J.</given-names></name> <name><surname>Glezer</surname> <given-names>A.</given-names></name> <name><surname>Potter</surname> <given-names>S. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Culturing thick brain slices: an interstitial 3D microperfusion system for enhanced viability</article-title>. <source>J. Neurosci. Methods</source> <volume>180</volume>, <fpage>243</fpage>&#x2013;<lpage>254</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jneumeth.2009.03.016</pub-id>, PMID: <pub-id pub-id-type="pmid">19443039</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname> <given-names>M.</given-names></name> <name><surname>Vidovic</surname> <given-names>N.</given-names></name> <name><surname>Biber</surname> <given-names>K.</given-names></name> <name><surname>Dolga</surname> <given-names>A.</given-names></name> <name><surname>Culmsee</surname> <given-names>C.</given-names></name> <name><surname>Dodel</surname> <given-names>R.</given-names></name></person-group> (<year>2020</year>). <article-title>The neuroprotective role of microglial cells against amyloid beta-mediated toxicity in organotypic hippocampal slice cultures</article-title>. <source>Brain Pathol.</source> <volume>30</volume>, <fpage>589</fpage>&#x2013;<lpage>602</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bpa.12807</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname> <given-names>T.</given-names></name> <name><surname>Matsuba</surname> <given-names>Y.</given-names></name> <name><surname>Mihira</surname> <given-names>N.</given-names></name> <name><surname>Takano</surname> <given-names>J.</given-names></name> <name><surname>Nilsson</surname> <given-names>P.</given-names></name> <name><surname>Itohara</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Single app knock-in mouse models of Alzheimer's disease</article-title>. <source>Nat. Neurosci.</source> <volume>17</volume>, <fpage>661</fpage>&#x2013;<lpage>663</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.3697</pub-id>, PMID: <pub-id pub-id-type="pmid">24728269</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakairi</surname> <given-names>H.</given-names></name> <name><surname>Kamikubo</surname> <given-names>Y.</given-names></name> <name><surname>Abe</surname> <given-names>M.</given-names></name> <name><surname>Ikeda</surname> <given-names>K.</given-names></name> <name><surname>Ichiki</surname> <given-names>A.</given-names></name> <name><surname>Tabata</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>G protein-coupled glutamate and GABA receptors form complexes and mutually modulate their signals</article-title>. <source>ACS Chem. Neurosci.</source> <volume>11</volume>, <fpage>567</fpage>&#x2013;<lpage>578</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acschemneuro.9b00599</pub-id>, PMID: <pub-id pub-id-type="pmid">31977183</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname> <given-names>T.</given-names></name> <name><surname>Kaneko</surname> <given-names>K.</given-names></name> <name><surname>Okuno</surname> <given-names>M.</given-names></name> <name><surname>Wada</surname> <given-names>K.</given-names></name> <name><surname>Kashiyama</surname> <given-names>T.</given-names></name> <name><surname>Shimizu</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Membrane microdomain switching: a regulatory mechanism of amyloid precursor protein processing</article-title>. <source>J. Cell Biol.</source> <volume>183</volume>, <fpage>339</fpage>&#x2013;<lpage>352</lpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.200804075</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheiblich</surname> <given-names>H.</given-names></name> <name><surname>Dansokho</surname> <given-names>C.</given-names></name> <name><surname>Mercan</surname> <given-names>D.</given-names></name> <name><surname>Schmidt</surname> <given-names>S. V.</given-names></name> <name><surname>Bousset</surname> <given-names>L.</given-names></name> <name><surname>Wischhof</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes</article-title>. <source>Cells</source> <volume>184</volume>:<fpage>e5021</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2021.09.007</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname> <given-names>D. J.</given-names></name></person-group> (<year>1991</year>). <article-title>The molecular pathology of Alzheimer's disease</article-title>. <source>Neuron</source> <volume>6</volume>, <fpage>487</fpage>&#x2013;<lpage>498</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0896-6273(91)90052-2</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sethi</surname> <given-names>M. K.</given-names></name> <name><surname>Zaia</surname> <given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Extracellular matrix proteomics in schizophrenia and Alzheimer's disease</article-title>. <source>Anal. Bioanal. Chem.</source> <volume>409</volume>, <fpage>379</fpage>&#x2013;<lpage>394</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00216-016-9900-6</pub-id>, PMID: <pub-id pub-id-type="pmid">27601046</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shinoda</surname> <given-names>Y.</given-names></name> <name><surname>Kamikubo</surname> <given-names>Y.</given-names></name> <name><surname>Egashira</surname> <given-names>Y.</given-names></name> <name><surname>Tominaga-Yoshino</surname> <given-names>K.</given-names></name> <name><surname>Ogura</surname> <given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Repetition of mGluR-dependent LTD causes slowly developing persistent reduction in synaptic strength accompanied by synapse elimination</article-title>. <source>Brain Res.</source> <volume>1042</volume>, <fpage>99</fpage>&#x2013;<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2005.02.028</pub-id>, PMID: <pub-id pub-id-type="pmid">15823258</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stachel</surname> <given-names>S. J.</given-names></name> <name><surname>Coburn</surname> <given-names>C. A.</given-names></name> <name><surname>Steele</surname> <given-names>T. G.</given-names></name> <name><surname>Jones</surname> <given-names>K. G.</given-names></name> <name><surname>Loutzenhiser</surname> <given-names>E. F.</given-names></name> <name><surname>Gregro</surname> <given-names>A. R.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1)</article-title>. <source>J. Med. Chem.</source> <volume>47</volume>, <fpage>6447</fpage>&#x2013;<lpage>6450</lpage>. doi: <pub-id pub-id-type="doi">10.1021/jm049379g</pub-id>, PMID: <pub-id pub-id-type="pmid">15588077</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stoppini</surname> <given-names>L.</given-names></name> <name><surname>Buchs</surname> <given-names>P. A.</given-names></name> <name><surname>Muller</surname> <given-names>D.</given-names></name></person-group> (<year>1991</year>). <article-title>A simple method for organotypic cultures of nervous tissue</article-title>. <source>J. Neurosci. Methods</source> <volume>37</volume>, <fpage>173</fpage>&#x2013;<lpage>182</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0165-0270(91)90128-M</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tominaga-Yoshino</surname> <given-names>K.</given-names></name> <name><surname>Kondo</surname> <given-names>S.</given-names></name> <name><surname>Tamotsu</surname> <given-names>S.</given-names></name> <name><surname>Ogura</surname> <given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Repetitive activation of protein kinase a induces slow and persistent potentiation associated with synaptogenesis in cultured hippocampus</article-title>. <source>Neurosci. Res.</source> <volume>44</volume>, <fpage>357</fpage>&#x2013;<lpage>367</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0168-0102(02)00155-4</pub-id>, PMID: <pub-id pub-id-type="pmid">12445624</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>P. V.</given-names></name> <name><surname>Hickman</surname> <given-names>D. L.</given-names></name> <name><surname>Van Luijk</surname> <given-names>J.</given-names></name> <name><surname>Ritskes-Hoitinga</surname> <given-names>M.</given-names></name> <name><surname>Sargeant</surname> <given-names>J. M.</given-names></name> <name><surname>Kurosawa</surname> <given-names>T. M.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Welfare impact of carbon dioxide euthanasia on laboratory mice and rats: a systematic review</article-title>. <source>Front. Vet. Sci.</source> <volume>7</volume>:<fpage>411</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fvets.2020.00411</pub-id>, PMID: <pub-id pub-id-type="pmid">32793645</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uesaka</surname> <given-names>N.</given-names></name> <name><surname>Abe</surname> <given-names>M.</given-names></name> <name><surname>Konno</surname> <given-names>K.</given-names></name> <name><surname>Yamazaki</surname> <given-names>M.</given-names></name> <name><surname>Sakoori</surname> <given-names>K.</given-names></name> <name><surname>Watanabe</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Retrograde signaling from Progranulin to Sort1 counteracts synapse elimination in the developing cerebellum</article-title>. <source>Neuron</source> <volume>97</volume>, <fpage>796.e5</fpage>&#x2013;<lpage>805.e5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2018.01.018</pub-id>, PMID: <pub-id pub-id-type="pmid">29398357</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uesaka</surname> <given-names>N.</given-names></name> <name><surname>Mikuni</surname> <given-names>T.</given-names></name> <name><surname>Hashimoto</surname> <given-names>K.</given-names></name> <name><surname>Hirai</surname> <given-names>H.</given-names></name> <name><surname>Sakimura</surname> <given-names>K.</given-names></name> <name><surname>Kano</surname> <given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Organotypic coculture preparation for the study of developmental synapse elimination in mammalian brain</article-title>. <source>J. Neurosci.</source> <volume>32</volume>, <fpage>11657</fpage>&#x2013;<lpage>11670</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1097-12.2012</pub-id>, PMID: <pub-id pub-id-type="pmid">22915109</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vassar</surname> <given-names>R.</given-names></name> <name><surname>Bennett</surname> <given-names>B. D.</given-names></name> <name><surname>Babu-Khan</surname> <given-names>S.</given-names></name> <name><surname>Kahn</surname> <given-names>S.</given-names></name> <name><surname>Mendiaz</surname> <given-names>E. A.</given-names></name> <name><surname>Denis</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</article-title>. <source>Science</source> <volume>286</volume>, <fpage>735</fpage>&#x2013;<lpage>741</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.286.5440.735</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vinet</surname> <given-names>J.</given-names></name> <name><surname>Weering</surname> <given-names>H. R.</given-names></name> <name><surname>Heinrich</surname> <given-names>A.</given-names></name> <name><surname>Kalin</surname> <given-names>R. E.</given-names></name> <name><surname>Wegner</surname> <given-names>A.</given-names></name> <name><surname>Brouwer</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Neuroprotective function for ramified microglia in hippocampal excitotoxicity</article-title>. <source>J. Neuroinflammation</source> <volume>9</volume>:<fpage>27</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1742-2094-9-27</pub-id>, PMID: <pub-id pub-id-type="pmid">22293457</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willem</surname> <given-names>M.</given-names></name> <name><surname>Tahirovic</surname> <given-names>S.</given-names></name> <name><surname>Busche</surname> <given-names>M. A.</given-names></name> <name><surname>Ovsepian</surname> <given-names>S. V.</given-names></name> <name><surname>Chafai</surname> <given-names>M.</given-names></name> <name><surname>Kootar</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Eta-Secretase processing of APP inhibits neuronal activity in the hippocampus</article-title>. <source>Nature</source> <volume>526</volume>, <fpage>443</fpage>&#x2013;<lpage>447</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature14864</pub-id>, PMID: <pub-id pub-id-type="pmid">26322584</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Q.</given-names></name> <name><surname>Shaikh</surname> <given-names>M. A.</given-names></name> <name><surname>Meymand</surname> <given-names>E. S.</given-names></name> <name><surname>Zhang</surname> <given-names>B.</given-names></name> <name><surname>Luk</surname> <given-names>K. C.</given-names></name> <name><surname>Trojanowski</surname> <given-names>J. Q.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo</article-title>. <source>Acta Neuropathol.</source> <volume>140</volume>, <fpage>831</fpage>&#x2013;<lpage>849</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-020-02227-6</pub-id>, PMID: <pub-id pub-id-type="pmid">33021680</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>Y. I.</given-names></name> <name><surname>Bassit</surname> <given-names>B.</given-names></name> <name><surname>Zhu</surname> <given-names>L.</given-names></name> <name><surname>Yang</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>Y. M.</given-names></name></person-group> (<year>2007</year>). <article-title>{gamma}-Secretase substrate concentration modulates the Abeta42/Abeta40 ratio: implications for Alzheimer disease</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume>, <fpage>23639</fpage>&#x2013;<lpage>23644</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M704601200</pub-id>, PMID: <pub-id pub-id-type="pmid">17556361</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimbone</surname> <given-names>S.</given-names></name> <name><surname>Monaco</surname> <given-names>I.</given-names></name> <name><surname>Giani</surname> <given-names>F.</given-names></name> <name><surname>Pandini</surname> <given-names>G.</given-names></name> <name><surname>Copani</surname> <given-names>A. G.</given-names></name> <name><surname>Giuffrida</surname> <given-names>M. L.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells</article-title>. <source>Aging Cell</source> <volume>17</volume>:<fpage>e12684</fpage>. doi: <pub-id pub-id-type="doi">10.1111/acel.12684</pub-id>, PMID: <pub-id pub-id-type="pmid">29094448</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item>
<term>AD, Alzheimer&#x2019;s disease</term>
</def-item>
<def-item>
<term>APP, amyloid precursor protein</term>
</def-item>
<def-item>
<term>A&#x03B2;, amyloid &#x03B2; peptide</term>
</def-item>
<def-item>
<term>DG, dentate gyrus</term>
</def-item>
<def-item>
<term>DIV, days <italic>in vitro</italic></term>
</def-item>
<def-item>
<term>GBSS, Gay&#x2019;s BSS</term>
</def-item>
<def-item>
<term>PBS, phosphate-buffered saline</term>
</def-item>
<def-item>
<term>OHP, overhead projector</term>
</def-item>
<def-item>
<term>TBS, Tris-buffered saline</term>
</def-item>
</def-list>
</glossary>
</back>
</article>